| 名稱(chēng) | FLT3-ITD D835H/BaF3 |
| 型號(hào) | CBP73239 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | FLT3-ITD [D835H]/BaF3,母細(xì)胞：BaF3，凍存條件：90% FBS+10% DMSO |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- 羅氏免疫療法獲FDA批準(zhǔn)治療晚期非小細(xì)胞肺癌（NSCLC）
- 從諾輝財(cái)報(bào)看甲基化市場(chǎng)，科佰生物助力甲基化標(biāo)準(zhǔn)品的開(kāi)發(fā)
- GLP1R藥靶篩選模型應(yīng)用展示
- 拯救偏頭痛！CGRP及其受體拮抗劑研究進(jìn)展
- 【產(chǎn)品推介】RANKL抗體篩選模型
- ATCC細(xì)胞的實(shí)驗(yàn)要點(diǎn)及說(shuō)明
- CD27細(xì)胞篩選模型
- 黑色素瘤研究進(jìn)展一覽
- CD200/CD200R篩選模型
- 認(rèn)識(shí)下北京細(xì)胞庫(kù)的質(zhì)量管理要求
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73239FLT3-ITD D835H/BaF3
- 詳細(xì)內(nèi)容
| CBP73239 | |
| I. Introduction | |
Cell Line Name： | FLT3-ITD [D835H]/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
| II.Background | |
FLT3, receptor-type tyrosine-protein kinase FLT3, activates Akt, Ras, and Erk pathways to regulate differentiation, proliferation, and survival of hematopoietic progenitor cells (PMID: 29316714, PMID: 28538663). Activating mutations of FLT3 are common in hematologic tumors (PMID: 19467916) and the internal tandem duplication (ITD) mutation is commonly observed in acute myeloid leukemia (PMID: 30181385). | |
| III. Representative Data | |
1.FLT3-ITD [D835H]/BaF3 | |
2. Anti-proliferation assay | |
Figure . Anti-proliferation assay of three reference compounds on the FLT3-ITD [D835H]/BaF3 Stable Cell Line. | |
會(huì)員_a.png)